Definition?
Atrial Fibrillation is a supraventricular tachyarrhythmia, characterised by uncoordinated atrial electrical activity.
Types?
Paroxysmal <7 days
Persistent/permanent-> 7 days-remodelling constant
Risk factors?
For Acute? PARASITE
Pulmonary disease Anaemia Rheumatic heart disease Atrial myxoma Sepsis Ischaemia Thyroid disease Ethanol
Differentials and features?
Epidemiology?
Age: older
Sex: male
Ethnicity:
Prevalence:
Clinical Presentation?
Pathophysiology?
• Supra ventricular tachycardia-atria don’t contract in a synchronised way and quiver
• LA-stasis-clotting-embolization-stroke
• Trigger-ectopic foci-impulse generated from pacemaker cells in place other than -SAN-usually pulmonary veins on left-fire rapidly
• AVN picks up impulses irregularly-and relays them to the ventricles irregularly
R-entry circuit-IHD, age HT-change atrial shape-diff conductivities/excitability-shorter refractory periods- shorter re-excitement and re-entry circuit-unsynchronised rhythms relayed through AVN
Investigations-first line?
Cardio/resp exam-Signs of arrhythmias
Investigations-second line?
Management-first line?
Stroke prevention-anticoagulation-unless LAA occlusion
NV-NOAD’s
V-warfarin
Management second line? 1 and 2 step drugs
Controlling rate-
1-CCB and beta blocker/digoxin
2-BB, diltiazem and digoxin
Management third line? 1 and 2 step
Controlling rhythm-
1-Cardioversion-pharm/electrical
2-dromodarone and bb
Management 4th line?
Ablation-surgical or catheter
Management acute?
anticoagulation-heparin or pharm
Management after surgery?
anticoagulants and rhythm control
Second line if acute?
Felcainide-Class I AA-stops Na influx in AVPs
or amiodarone if no heart disease
Amiodarone if structural heart disease
Prognosis?
Depends on underlying disorders
Poor if linked to MI
Complications?
Acute stroke MI CHF Airway disease Ablation-surgical/catheter Death Bradycardia Pro-arrhythmic drugs Amiodarone linked pulmonary toxicity and thyroid dysfunction